Notably, recent studies have identified mutations in RASA1 and EPHB4 in CM-AVM and Parkes Weber syndrome, respectively, highlighting the potential utility of genetic testing in complex cases. The gene discussed is EPHB4; the disease is angioosteohypertrophic syndrome.